PMID- 23224211 OWN - NLM STAT- MEDLINE DCOM- 20140310 LR - 20211021 IS - 1433-0423 (Electronic) IS - 0941-293X (Linking) VI - 110 IP - 8 DP - 2013 Aug TI - [Cytokine determination from vitreous samples in retinal vascular diseases]. PG - 746-54 LID - 10.1007/s00347-012-2719-4 [doi] AB - PURPOSE: The aim of this study was to determine cytokine levels from vitreous samples of treatment-naive patients with diabetic retinopathy (DRP), retinal vein occlusion (RVO) and exudative age-related macular degeneration (ARMD). METHODS: In this study 187 patients (median age 67 years, 101 males) were treated with a combined drug therapy including a 23-gauge core vitrectomy. Interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1) and intravitreal vascular endothelial growth factor (VEGF-A) levels were determined a using cytometric bead assay (CBA) and compared to those of the control group. RESULTS: Compared to the control group all diseases had significantly elevated cytokine levels, except VEGF in ARMD. In DRP samples of patients with diffuse diabetic macula edema (DME) higher VEGF-A and MCP-1 levels were found than in patients with focal DME. Ischemic DRP had higher VEGF levels than non-ischemic DRP. All measured cytokines were significantly higher in central retinal vein occlusion (CRVO) than in branch retinal vein occlusion (BRVO). CONCLUSIONS: Differences in intravitreal cytokine levels in DRP, RVO and ARMD could be demonstrated. The knowledge of depicted specific characteristic dysregulation of cytokines could allow more targeted future therapies. FAU - Pfister, M AU - Pfister M AD - Universitatsaugenklinik, Goethe Universitat, Theodor Stern Kai 7, 60590, Frankfurt am Main, Deutschland. marcel.pfister@kgu.de FAU - Koch, F H AU - Koch FH FAU - Cinatl, J AU - Cinatl J FAU - Rothweiler, F AU - Rothweiler F FAU - Schubert, R AU - Schubert R FAU - Singh, P AU - Singh P FAU - Ackermann, H AU - Ackermann H FAU - Koss, M J AU - Koss MJ LA - ger PT - English Abstract PT - Journal Article TT - Zytokinbestimmung aus Glaskorperproben bei retinalen Gefasserkrankungen. PL - Germany TA - Ophthalmologe JT - Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft JID - 9206148 RN - 0 (Biomarkers) RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Cytokines) RN - 0 (Interleukin-6) RN - 0 (Vascular Endothelial Growth Factor A) SB - IM MH - Aged MH - Biomarkers/analysis MH - Chemokine CCL2/*analysis MH - Cytokines/analysis MH - Female MH - Germany/epidemiology MH - Humans MH - Interleukin-6/*analysis MH - Male MH - Middle Aged MH - Prevalence MH - Reproducibility of Results MH - Retinal Diseases/diagnosis/*epidemiology/*metabolism MH - Retinal Vessels/*chemistry MH - Risk Factors MH - Sensitivity and Specificity MH - Vascular Endothelial Growth Factor A/*analysis MH - Vitreous Body/*chemistry EDAT- 2012/12/12 06:00 MHDA- 2014/03/13 06:00 CRDT- 2012/12/11 06:00 PHST- 2012/12/11 06:00 [entrez] PHST- 2012/12/12 06:00 [pubmed] PHST- 2014/03/13 06:00 [medline] AID - 10.1007/s00347-012-2719-4 [doi] PST - ppublish SO - Ophthalmologe. 2013 Aug;110(8):746-54. doi: 10.1007/s00347-012-2719-4.